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The preferential retention of the arginine allele at the p53 codon 72 locus is commonly observed in tumours from arginine/proline
heterozygotes. Considering that cancer cells are harboured in a hypoxic environment in vivo, we here tested the hypothesis that the
p53 codon 72 proline allele confers a survival disadvantage in presence of hypoxia. Here, we show that the transient transfection of
the proline allele in p53 null cancer cells exposed to low oxygen tension or to the hypoxia-mimetic drug Desferoxamine induces a
higher amount of cell death than the arginine allele. Accordingly, proline allele transiently transfected cell lines express lower levels of
hypoxia pro-survival genes (HIF-1a, carbonic anhydrase IX, vascular endothelial growth factor, heme oxygenase-I, hepatocyte growth
factor receptor, vascular endothelial growth factor receptor 2), compared to those transiently transfected with the arginine allele.
Further, we report that the exposure of the arginine/proline heterozygote MCF-7 breast cancer cell line to cytotoxic concentration of
Desferoxamine for several weeks, gives raise to hypoxia-resistant clones, carrying the arginine, but not the proline allele. These data
indicate that the p53 codon 72 proline allele is less permissive for the growth of cancer cells in a hypoxic environment, and suggest
that the preferential retention of the arginine allele in the tumour tissues of arginine/proline heterozygous patients may depend upon
its lowered capacity to induce cell death in a hypoxic tumour environment.
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The codon 72 arginine-to-proline polymorphism at the p53 locus
affects cancer development, as well as response to therapy and
survival of cancer patients (Thomas et al, 1999; Marin et al, 2000;
Bergamaschi et al, 2003; Bonafe et al, 2003). The N-terminal
polyproline-rich domain, in which the polymorphism is har-
boured, interacts with numerous proteins that are active players in
the process of gene transcription and cell death (Baptiste et al,
2002). In particular, the two p53 codon 72 alleles show a functional
difference in the binding to transcription factors (e.g., TAF30II)
and in the interaction with the cell death regulatory proteins
MDM-2, Bcl-2, Bcl-xL and iASPP (Matlashewski et al, 1987;
Dumont et al, 2003; Bonafe et al, 2004; Hammond and Giaccia,
2005; Bergamaschi et al, 2006). The arginine allele is preferentially
retained (i.e., the proline allele is preferentially lost) in cancer cells
and in tumour tissues of arginine/proline heterozygous cancer
affected patients (Brooks et al, 2000; Anzola et al, 2003; Bonafe
et al, 2003; Schneider-Stock et al, 2004). The phenomenon has
been attributed to the inactivation of the pro-apoptotic TP73 gene
induced by the mutated arginine, but not proline allele (Marin
et al, 2000). In fact, several reports indicate that the arginine allele
is a better inducer of apoptosis in vitro (Bonafe et al, 2002, 2004;
Dumont et al, 2003). However, the relevance of such a functional
difference between the p53 codon 72 alleles for tumour growth in
vivo has not yet been understood. Wild-type p53 protein induces
cell death in response to hypoxia (Graeber et al, 1996; Semenza,
2003). Clones of cells lacking active p53 have a survival advantage
in a hypoxic environment (Graeber et al, 1996), consistently, the
hypoxic environment present in the tumour mass in vivo is
supposed to select clones carrying defective p53 (Graeber et al,
1996; Semenza, 2003). Interestingly, the p53-mediated suppression
of hypoxia survival genes, such as carbonic anhydrase IX and
vascular endothelial growth factor has been reported (Koumenis
et al, 2001; Pal et al, 2001; Kaluzova et al, 2004). Such a repressor
activity has been proposed to be more relevant than the p53-
mediated induction of pro-apoptotic genes in determining cell
death in presence of hypoxia (Hammond and Giaccia, 2005;
Hammond et al, 2006). We here tested the hypothesis that the p53
codon 72 alleles differ in the capacity to induce cell death in
presence of hypoxia. We found that the proline allele confers a
survival disadvantage to cancer cells exposed to hypoxic environ-
ment. We speculate that such a difference will help to understand
the mechanism at the basis of the preferential retention of the
arginine allele in tumour tissues in vivo.
MATERIALS AND METHODS
Cell culture and reagents
All culture media (Rosewell Park Memorial Institute (RPMI)-1640,
F-12K, Low glucose Dulbecco’s modified Eagle’s medium
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s(DMEM)), fetal bovine serum (FBS), L-glutamine, penicillin/
streptomycin were purchased from Euroclone (Milan, Italy).
MCF-7 cells were grown in RPMI-1640 medium, supplemented
with 10% FBS; PC-3 cells were grown in F-12K medium
supplemented with 10% FBS; HEP-3B cells were grown in low
glucose DMEM, supplemented with 10% FBS; MDA-MB-157 cells
were grown in 50:50 mixture of DMEM/F-12K media, supple-
mented with 5% FBS. All the cultures were kept at 371Ci na5 %
CO2-humidified atmosphere.
Exposure to severe hypoxia and to the hypoxia mimetic
desferoxamine
Severe hypoxia (o0.1% O2) was generated in a humidified
incubator supplied with 95% N2/5% CO2 (Thermoforma, Thermo,
Waltham, MA, USA). Desferoxamine (DFX) (Sigma, St. Louis, MO,
USA) was used as hypoxia mimetic. MCF-7 cells were exposed to
various concentrations of DFX (100–500mM), for 4 weeks. After a
massive cell death, several (20) clones were isolated in 100mM
administered cultures, and were genotyped for the p53 codon 72
polymorphism (Supplementary Figure 1). No clones were obtained
when 4100mM of DFX was used. The clone endowed with the
best capacity of in vitro growth (clone number 7, HYPO-7) was
extensively passaged and cultured for at least 1 year in absence of
DFX, without appreciable changes in morphology and gene
expression (Supplementary Figure 2).
Transient transfection of the p53 codon 72 alleles encoding
plasmids
Plasmids encoding the p53 codon 72 proline or arginine allele were
obtained by cloning the entire p53cDNA into a pCMS-GFP
expression vector (Clontech, Palo Alto, CA, USA), as described
elsewhere (Bonafe et al, 2004). To perform transient transfection in
3cm
2 wells, 60% confluent cells were incubated with 800ng of
plasmid for 24h, in the presence of the transfection reagent
Lipofectamine 2000 at a ratio of 1:3 (Invitrogen, Carlsbad, CA,
USA). Transfection efficiency was scored using fluorescent
microscopy of the GFP-expressing cells.
Stable retroviral tranduction with dominant-negative mini
p53 protein
Retroviral gene transfer was performed as described previously
(Per et al, 1993). Briefly, Phoenix cells (kindly provided by Dr K
Marcu, Department of Molecular Biology, University of New York
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Figure 1 The inactivation and the downregulation of p53 enhances survival of MCF-7 cells in presence of hypoxia. (A) Exposure to severe hypoxia
(o0.1% O2) or to 100mM DFX for 24h: Western blot (WB) analysis of p53 protein, RT-PCR analysis of carbonic anhydrase IX (CA-IX), VEGF, heme
oxygenase-I (HO-I) (B) MCF-7 cells infected with a pBabePuro retroviral vector, empty (Ctrl) or encoding a p53 dominant-negative mini-protein (p53D), or
exposed to a p53-specific or control (Scr) siRNA: cell death analysis, n¼3, *P¼0.008; **P¼0.043; ***P¼0.015; ANOVA test, data are expressed as
mean7s.d. (upper panel); RT-PCR analysis of CA-IX, VEGF, HO-I, PUMA, NOXA, BNIP3L and b2mm RNA level (middle panel), WB and RT-PCR analysis
of p53 protein and mRNA level (lower panel).
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sat Stony Brook, New York, USA) were grown at 85% confluence
and were transfected overnight with 10mg of the retroviral pBabe-
puro plasmid, either empty or encoding a dominant negative
p53-miniprotein (p53D), provided by Dr M. Oren (The Weizman
Institute Rehovot, Israel). P53D is a C-terminal fragment of p53
that retains the multimerisation, but not the transcriptional
transactivation domain, and it forms transcriptionally inactive
multimers with endogenous wild-type p53 protein, which in turn
accumulate in the cells owing to the lack of MDM2-mediated
degradation (Shaulian et al, 1992). Two days after transfection, the
medium containing newly packaged retrovirus was collected and
filtered through a 0.45-mm pore size filter. After supplementation
with 4mgml
 1 polybrene (Sigma), the augmented medium was
applied to MCF-7 cells at 50% for 24h. Puromycin 2mgml
 1
(Sigma) was used as a selection agent to isolate successfully
transduced cells.
Double-strand RNA oligonucleotide-mediated p53 gene
silencing
For the oligonucleotide-mediated silencing of the p53 gene we
used predesigned p53-specific short interfering double-
strand RNA oligonucleotide (GCAUGAACCGGAGGCCCA
sense, AUGGGCCUCCGGUUCAUG, antisense) and a non-specific
short interfering RNA (siRNA) control oligonucleotide (UUCU
CCGAACGUGUCACG sense, ACGUGACACGUUCGGAGA, anti-
sense), (Qiagen, Valencia, CA, USA). Transfection procedures
were performed using Lipofectamine 2000 (Invitrogen). Briefly,
60% confluent MCF-7 cells were incubated with 1mg of p53
or control siRNA for 4h, and then incubated for additional
24h in fresh complete RPMI-1640 medium supplemented
with 10% FBS. The efficiency of gene silencing ranged between
70 and 90%.
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Figure 2 The p53 codon 72 proline allele is more cytotoxic with respect to arginine allele in presence of hypoxia. PC-3 cells exposed to 100mM DFX,
HEP-3B and MDA-MB-157 exposed to o0.1% O2, transiently transfected with p53 codon 72 arginine- (p53Arg) or proline- (p53Pro) allele encoding, or
empty (-) pCMS-GFP expression vector. (A) cell death analysis (n¼3), *P¼0.016; **P¼0.006;***P¼0.008; Bonferroni-corrected post hoc test, data are
expressed as mean7s.d. (upper panel); RT-PCR analysis of CA-IX, VEGF, HO-I, c-MET, KDR, BNIP3L, NOXA, PUMA and b2mm RNA level (middle panel);
Western blot analysis of p53 and b-actin (Note the faster migration rate of the p53Arg, with respect to the p53Pro allele, lower panel), (B) cell death
analysis (n¼3), *P¼0.049; **P¼0,016; NS¼not significant; Bonferroni-corrected post hoc test; data are expressed as mean7s.d. (upper panel), RT-PCR
analysis of VEGF, HO-1, c-MET, b2m mRNA level; ND, not detectable (lower panel), (C) RT-PCR analysis of HIF-1a and b2mm RNA level in PC-3, MDA-
157, HEP-3B cells, exposed to o0.1% O2 for 24h and transfected with p53Arg or p53Pro or (-) pCMS-GFP vector. (D) Western blot analysis of CA-IX,
VEGF, HIF-1a, p53, b-actin in HEP-3B cells, exposed to 100mM DFX for 24h and transiently transfected with p53Arg or p53Pro or (-) pCMS-GFP vector.
Transfection efficiency was evaluated by fluorescent microscopy analysis of GFP-positive cells (data not shown).
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heterozygosity at p53 locus analyses
The DNA and cDNA sequences containing the p53 codon 72
polymorphism were amplified using a standard PCR protocol with
the following primers: FW,5 0-GAC CCAGGTCCAGATGAAGCT-30,
RV,5 0-ACCGTAGCTGCCCTGGTAGGT-30. PCR conditions were as
follows: initial denaturation at 941C for 3min, 29 cycles with
denaturation at 941C for 1min, annealing at 63.51C for 1min and
extension at 721C for 1min, followed by final extension at 721C for
7min. The 156bp PCR product was digested with restriction
enzyme BstUI (New England Biolabs, Beverly, MA, USA), which
recognises a restriction site on the arginine allele, yielding a 109bp
fragment (and an undetectable band of 47bp). The entire p53
cDNA was amplified by using the following primers, 50-GCCATG
GAGGAGCCGCAGTC-30 and 50-TCAGTCTGAGTCAGGCCCTT-30.
The 1189bp fragment was sequenced in a CEQ8000 Automatic
Sequencer (Beckman, Fullerton, CA, USA), using the following
primers: 50-GCCATGGAGGAGCCGCAGTC-30;5 0-GCCCCTCCTCA
GCATCTTAT-30;5 0-TCAGTCTGAGTCAGGCCCTT-30;5 0-GACCCA
GGTCCAGATGAAGCT-30;5 0-ACCGTAGCTGCCCTGGTAGGT-30.
The sequence analysis revealed the presence of a wild type TP53
in both MCF-7 and HYPO-7 (data not shown). Loss of hetero-
zygosity at p53 locus was assessed by amplifying the 100–120bp
region located in Intron I of the TP53 gene, using the following
primers: 50-ACTCCAGCCTGGGCAATAAGAGCT-30;5 0-ACAAACA
TCCCCTACCAAACAGC-30. Previous reports indicate that the
above region is in tight linkage with p53 codon 72 locus
(Schneider-Stock et al, 2004). The amplified fragments were
separated on an ethidium bromide-stained 2% agarose gel.
RNA extraction and reverse transcription cDNA
amplification
Total RNA was extracted from cells using TRIzol
s Reagent
(Invitrogen) according to the manufacturer’s instructions. Reverse
transcription reaction was performed in a 20ml volume with 2mgo f
total RNA using the M-MLV Reverse Transcriptase (Invitrogen),
following the manufacturer’s protocol. Oligo-(dT)12-18 primers
(Invitrogen) were used for the first strand synthesis. The following
primers were used to amplify the target genes mRNA: vascular
endothelial growth factor (VEGF): FW: 50-GAGAATTCGGCCTCCG
AAACCATGAACTTTCTGCT-30 and RV: 50-GAGCATGCCCTCC
TGCCCGGCTCACCGC-30, annealing temperature 651C, amplicons
length: 520, 600 and 675bp; carbonic anhydrase IX (CA-IX): FW:
50-CAGGGACAAAGAAGGGGATGAC-30; RV: 50-TTGGAAGT
AGCGGCTGAAGTCA-30, annealing temperature 611C, amplicon
length 589bp; Heme Oxigenase-I (HO-I): FW: 50-CCCGACAGC
ATGCCCCAGGAT-30; RV: 50-GGAGTTCATGCGGGAGCGGTA
GAG-30, annealing temperature 601C, amplicon length 549bp;
hepatocyte growth factor receptor (c-MET): FW: 50-ACAGTGGC
ATGTCAACATCGCT-30; RV: 50-CTTAGACATCTGATGGCTCG-30,
annealing temperature 621C, amplicon length 656bp; vascular
endothelial growth factor receptor-2 (KDR): FW: 50-TATAGAT
GGTGTAACCCGGA-30; RV: 50-TTTGTCACTGAGACAGCTTGG-30,
annealing temperature 62C, amplicon length 656bp; Hypoxia
Induced Factor-1alpha (HIF-1a): FW: 50-GGTGAATATGTCT
GGGTTGAAAC-30, RV: 50-TGGGACTATTAGGCTCAGGTGAA-30,
annealing temperature 561C, amplicon length 615bp; PUMA:
50-CAGACTGTGAATCCTGTGCT-30 RV: 50-ACAGTATCTTACA
GGCTGCC-30, annealing temperature: 621C, amplicon length:
285bp; NOXA: FW: 50-GTGCCCTTGGAAACGGAAGA-30, RV:
50-CCAGCCGCCCAGTCTAATCA-30, annealing temperature:
641C, amplicon length: 258bp; BNIP3L: FW: 50-CTCAGTCAGAA
GAAGAAGTTGTAG A-30, RV: 50-CTCAGTCGCTTTCCAATATA
GAT-30, annealing temperature 511C, amplicon length: 283bp;
b2-microglobulin (b2m): FW:50-ACCCCCACTGAAAAAGATGA-30;
RV: 50-ATCTTCAAACCTCCATGATG-30, annealing temperature
581C, amplicon length 114bp . All PCR protocols were performed
as follows: predenaturation step at 951C for 2min; 28 cycles of
denaturation at 951C for 1min, annealing at the appropriate
temperature for 1min, extension at 721C for 1min; final extension
at 721C for 7min. Amplified fragments were resolved onto a 1.8%
agarose gel.
Western blot analysis
Cell lysates were prepared using coimmunoprecipitation buffer
(10mM HEPES, 142mMKCl, 2.5 MgCl2,1 m M EDTA, 1mM DTT,
0.2% NP-40) supplemented with a protease and phosphatase
inhibitors cocktail (Sigma). Total protein lysate (100mg) was
loaded onto an 8% acrylamide/bis-acrylamide gel, and transferred
to Hybond, nitrocellulose membrane (Amersham Biosciences,
Buckingamshire, UK). Antibodies for WB analysis were directed
against: p53 (DO-I Mouse Monoclonal antibody, Santa Cruz
Biotechnology, Santa Cruz, CA), CA-IX (Mouse Monoclonal
antibody, Clone M75, kindly provided by J Pastorek, Slovak
Academy of Sciences, Bratislava, Slovak Republic), HIF-1a and
VEGF (Rabbit Polyclonal Antibodies, Upstate, Charlottesville, VA,
USA), b-actin (Sigma). HRP-conjugated secondary antibodies were
visualised by the luminol/enhancer chemiluminescent substrate
(Amersham Biosciences).
Cell death assessment
Cell death was evaluated by propidium iodide exclusion and
analysed in a FACSaria (Becton Dickinson, San Jose `, CA, USA)
Statistical analysis
Associations among variables were verified using Student’s t-test
or analysis of variance (ANOVA). Bonferroni-corrected post hoc
test was used for pairwise comparisons following a significant
F-test. Statistical calculations were executed with SPSS 10.1
Software Package (SPSS Inc, Chicago, IL, USA). Data in graphs
are expressed as mean7s.d.
RESULTS
p53 promotes cell death and represses the expression of
hypoxia pro-survival genes in MCF-7 cells exposed to
hypoxia
We began this investigation by examining the role of the p53
inactivation in hypoxia-induced cell death in MCF-7. First, we
generated a puromycin-resistant MCF-7 polyclonal population
stably transduced with a pBabe retroviral vector, either empty or
encoding a dominant-negative mini p53 protein (p53D), which
hampers the activity of p53 by accumulating the protein in the
cytoplasm (Shaulian et al, 1992). Second, we transiently transfected
parental MCF-7 cells with a p53-specific short interfering RNA
(p53 siRNA), which brings to a substantial reduction in the p53
mRNA level. We then exposed the cells to severe hypoxia (o0.1%
O2) or to the hypoxia mimetic DFX, at a concentration of 100mM,
and we found that both p53D-transduced cells and p53siRNA-
transfected MCF-7 cells exhibited a significantly lower rate of cell
death in comparison to the matched controls (Figure 1B, upper
panel). The phenomenon was paralleled by a marked increase in
the mRNA level of hypoxia response genes (Lee et al, 1997; Pal
et al, 2001; Kaluzova et al, 2004) namely, VEGF, carbonic
anhydrase IX (CA-IX), heme oxygenase-I (HO-I, Figure 1B, middle
panel). Interestingly, no differences were observed as far as
hypoxia-response/p53 regulated genes such as BNIP3L, PUMA and
NOXA are concerned see Figure 1B, (middle panel). These data
indicate that, in our experimental conditions, the lack of p53
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of hypoxia response genes.
The transfection of the p53 codon 72 proline allele
enhances cell death in cancer cells exposed to hypoxia
To ascertain whether the p53 codon 72 alleles show a functional
difference with regards to cell survival and regulation of hypoxia
response genes, p53-null cells (the breast cancer cell line MDA-
MB-157, the hepatocellular carcinoma cell line HEP-3B, the
prostate carcinoma cell line PC-3) were exposed to o0.1%. O2
and/or to 100mM DFX, and then transiently transfected with a
pCMS-GFP vector, either empty (-), or encoding the p53 codon 72
arginine (p53Arg) or proline (p53Pro) allele. We found that the
p53Pro allele induced a higher rate of cell death than the p53Arg
allele in all the three cell lines (Figure 2A, upper panel). Moreover,
though p53Arg/p53Pro transfected cells showed similar levels of
p53 protein (Figure 2A, lower panel), p53Arg allele-transfected
cells expressed higher levels of hypoxia survival genes, namely
CA-IX, VEGF, HO-I, hepatocyte growth factor receptor (c-MET),
and vascular endothelial growth factor receptor 2 (KDR), than
p53Pro-transfected ones (Figure 2A, middle panel). At variance,
the transfection of the p53Arg/p53Pro alleles in absence of hypoxic
environment, elicited a similar degree of cell death in HEP-3B cells
as well as the p53Arg allele elicited a higher degree of cell death
than the p53Pro in MDA-MB-157 and PC3 cells (Figure 2B). Since
the genes above are regulated by the hypoxia response transcrip-
tion factor HIF-1a at the promoter level (Lee et al, 1997; Pal et al,
2001; Pennacchietti et al, 2003; Kaluzova et al, 2004), we then
tested the hypothesis that the p53 codon 72 alleles exerts a direct
regulation on HIF-1a gene expression. We found that, in the
presence of o0.1% O2, p53Arg allele-transfected MDA-MB-157
and PC-3 cells, but not HEP3B, expressed a higher level of HIF-1a
gene mRNA than p53Pro-transfected ones (Figure 2C). Never-
theless, p53Arg-transfected HEP3B cells exposed to 100mM DFX,
showed increased levels of HIF-1a, CA-IX and VEGF protein in
respect to p53Pro-transfected ones (Figure 2D). These data suggest
that the p53Pro allele hampers the capacity of cancer cells in
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Figure 3 The p53Arg is retained in MCF-7-derived hypoxia-selected clones. (A) HYPO-7 and MCF-7 cells: PCR analysis of p53 codon 72 genotype on
genomic DNA (gDNA) and cDNA, Loss of heterozygosity at the (AAAAT)n pentanucleotide repeat located in the Intron I of the TP53 gene (upper); RT-
PCR analysis of CA-IX, VEGF, HO-I, c-MET, KDR and b2mm RNA level (lower). (B) HYPO-7 cells exposed to o0.1% O2 for 24h and transiently
transfected with p53Arg, p53Pro (-) pCMS-GFP vector: Cell death analysis (n¼3), *P¼0.028; Bonferroni-corrected post hoc test, data are expressed as
mean7s.d. (upper); RT-PCR analysis of CA-IX, VEGF, HO-I, KDR, c-MET, HIF-1a and b2mm RNA level (middle); Western blot analysis of CA-IX, VEGF,
HIF-1a, p53 and b-actin (lower). (C) pBabe-p53D stably transduced MCF-7 (MCF-7/p53D), exposed to o0.1% O2 for 24h, and transiently transfected with
p53Arg, p53Pro or (-) pCMS-GFP vector: cell death analysis (n¼3), *P¼0.035; Bonferroni-corrected post hoc test, data are expressed as mean7s.d.
(upper); RT-PCR analysis of CA-IX, VEGF, HO-I and b2mm RNA level (lower). Transfection efficiency was evaluated by fluorescent microscopy analysis of
GFP positive cells (data not shown).
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sa hypoxic environment by regulating HIF-1a at transcriptional or
post-transcriptional level, depending on the cell type examined.
The p53Arg allele is retained in hypoxia-resistant, MCF-7
derived clones
On the basis of the above results, it was reasoned that the p53Arg
allele may be preferentially retained in heterozygote tumour cells
owing to a survival advantage in presence of hypoxia. Following
this hypothesis, we analysed the p53 codon72 genotype of 20
clones, obtained by the long-term exposure of the p53Arg/Pro
heterozygote MCF-7 cell line to cytotoxic concentrations of DFX
(see Supplementary Figure 1). PCR analysis revealed that all of the
20 clones obtained carried the p53Arg, but not the p53Pro allele
(Supplementary Figure 1). HYPO-7 cells, the fastest growing clone,
was further tested for the loss of heterozigosity at the p53 locus, by
assessing the Intron I pentanucleotide repeat. The analysis
confirmed that only one of the two allele present in parental
MCF-7 cells was detectable in HYPO-7 cells (Figure 3A, upper
panel). Interestingly, HYPO-7 cells maintained higher expression
level of CA-IX, VEGF, HO-I, KDR mRNA than parental MCF-7
cells, even after several months of culture in absence of DFX
(Figure 3A, lower panel, and Supplementary Figure 2). We then
tested the capacity of the p53 codon 72 alleles to modulate the
response to hypoxia in HYPO-7 cells. We found that, in the
presence of o0.1% O2, the p53Pro allele transiently transfected
cells exhibited a higher rate of cell death, (Figure 3B, upper panel),
lower levels of CA-IX, VEGF, HO-I and KDR mRNA (Figure 3B,
middle panel), as well as a lower level of HIF-1a protein (Figure 3B,
lower panel), compared to the p53Arg allele-transfected ones. To
test further whether the p53 codon 72 alleles differ with regard to
hypoxia survival in a MCF-7 genetic background, we transiently
transfected pBabePuro-p53D stably-transduced MCF-7 cells with
p53Pro/p53Arg alleles. In line with the results above, in the
presence of o0.1% O2 the p53Pro allele elicited a higher degree of
cell death, as well as lower levels of CA-IX, VEGF, HO-I mRNA,
compared to the p53Arg allele (Figure 3C). These data suggest that
the loss of the p53Pro allele in p53 codon 72 heterozygous cancer
cells is associated with a survival advantage in presence of hypoxia.
DISCUSSION
The present study provides evidence that the p53Pro allele of
codon 72 locus confers a survival disadvantage to cancer cells in
presence of hypoxia. This enhanced cell death inducing activity of
the p53Pro allele in the presence of hypoxia, correlates with the
lack of upregulation of a variety of genes (e.g., CA-IX, VEGF,
c-MET, HO-I, KDR), whose promoters contain the consensus
sequence for the hypoxia-induced transcription factor HIF-1a (Lee
et al, 1997; Pal et al, 2001; Pennacchietti et al, 2003; Kaluzova et al,
2004). Accordingly, we found that HIF-1a protein and/or mRNA
are decreased in cells transfected with the p53Pro allele. In this
regard, it has been found that p53 downregulates HIF-1a at the
protein level, but also that p53  /  cells exposed to hypoxia show
an increase in HIF-1a mRNA level in respect to p53 wild-type cells
(Alarcon et al, 1999; Ravi et al, 2000; Nieminen et al, 2005). Hence,
the available data support the hypothesis of a multilevel regulation
of HIF-1a gene expression by p53. In this paper, we also show that
the exposure of arginine/proline heterozygote MCF-7 cells to the
hypoxia-mimetic drug Desferoxamine, yields the outgrowth of
arginine hemi-zygote clones. We propose that these results
support the notion that the p53Pro allele confers a growth
disadvantage in a hypoxic environment. Accordingly, the reintro-
duction of the p53Pro, but not the p53Arg allele in hypoxia
selected cells downregulates hypoxia response genes and promotes
hypoxia-induced cell death. At present, it is not clear whether the
p53Arg carrier, hypoxia selected clones are a sub-population that
is already present among parental MCF-7 cells, or arise as a
consequence of a hypoxia-induced genomic DNA damage. It is
worth noting, however, that no p53Pro hemi-zygote cells were
obtained from MCF-7 cells exposed to DFX (data not shown). In
conclusion, we propose that the result here presented may provide
a functional explanation for the preferential retention of the
p53Arg allele (the preferential loss of the p53Pro) in tumour tissues
of p53 codon 72 heterozygote individuals. Moreover, these data
may provide a functional cue for explaining the recently reported
reduction in vivo of the amount of spontaneous cell death in the
p53Arg-retaining tumours arisen in heterozygote individuals
(Schneider-Stock et al, 2004). Finally, we suggest that our results
contribute to explain the controversial association between p53
codon 72 polymorphism in cancer. Indeed, the p53Arg allele,
though provides survival advantage to cancer cells in the presence
of hypoxia, induces a higher susceptibility to cell death in absence
of such a stress condition (this paper, Bonafe et al, 2002; Dumont
et al, 2003; Bonafe et al, 2004). This behaviour adds up to a picture
of the same genotype having different effects in tumour malignant
progression depending on different microenvironmental condi-
tions, for example, the oxygenation level.
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